IGF-LR3 (Insulin-like Growth Factor I Long R3)
IGF-LR3 is a long-acting variant of insulin-like growth factor designed for research applications. The Long R3 modification extends the half-life and potency compared to native IGF-1, making it a preferred compound for laboratory investigations into growth signaling, muscle development, and metabolic pathways.
Applications
Myogenic Research: IGF-LR3 is extensively used in research examining muscle protein synthesis and myocyte differentiation. The extended half-life allows sustained signaling in cell culture and animal model systems, enabling researchers to study dose-dependent effects on muscle growth and development.
Metabolic Studies: Researchers utilize IGF-LR3 to investigate insulin-like growth factor signaling in glucose homeostasis, lipid metabolism, and nutrient partitioning. The Long R3 formulation enhances signal persistence in experimental protocols.
Growth Factor Pathways: IGF-LR3 serves as a research tool for examining IGF-1 receptor activation, downstream kinase cascades, and transcriptional responses in cellular and tissue-level investigations.
Technical Specifications
Molecular Formula: C77H125N23O22S (modified IGF-1)
Purity: ≥99% (verified by HPLC)
Molecular Weight: 1640.93 g/mol
Source: Recombinant (E. coli expression)
Quantity: 1mg per vial
Reconstitution: Compatible with bacteriostatic water or saline
Storage: -20°C (frozen), stable 12+ months
pH Range (reconstituted): 4.5–7.0
Quality & Purity
All Erosyn Labs IGF-LR3 batches undergo rigorous HPLC analysis and mass spectrometry verification to confirm identity, purity, and absence of contaminants. Third-party testing certifies potency and sterility for research applications.
For research use only. Not for human consumption.
